The low frequency of rearrangements involving ETV4, ETV5 and FLI1 (less than 2%), and the lack of cell line models harboring rearrangements of these ETS members, resulted in scarce knowledge of their oncogenic roles in prostate carcinogenesis. This evidence concerns the gene ETV4 and prostatitis.